Cited by 319Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsAcute Myeloid Leukemia Research

The DOI matches its Crossref record.

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Open access

Muindi, J, Frankel, SR, Miller, WH Jr, Jakubowski, A, Scheinberg, DA, Young, CW, Dmitrovsky, E, Warrell, RP Jr·1992·Blood

DOI 10.1182/blood.v79.2.299.299

Open this paper in CoChat — free account Open PDF

Abstract

Although all-trans retinoic acid (RA) induces complete remission in a high proportion of patients with acute promyelocytic leukemia (APL), all groups have described clinical relapses despite continued RA treatment. This finding suggests that resistance to the cytodifferentiating effects of the retinoid had been acquired. To investigate potential mechanisms of clinical resistance to RA, we serially evaluated the clinical pharmacology of the drug in APL patients treated with this agent. Leukemic cells from patients relapsing from RA treatment were cultured in the presence of RA and examined for evidence of morphologic maturation. We also studied messenger RNA expression of the newly described gene product of the (15;17) translocation in APL, PML/RA receptor-alpha (PML/RAR-alpha). Serial pharmacokinetic studies showed that continuous daily RA treatment was associated with a marked decrease in plasma drug concentrations at the time of relapse compared with the initial day of therapy. Doubling the RA dose in six patients failed to reinduce response at the time of relapse and also failed to significantly augment plasma RA concentrations. However, leukemic cells obtained at the time of relapse from four patients retained in vitro sensitivity to the differentiating activity of RA (10(-6) mol/L). No change was observed in the pattern of PML/RAR-alpha expression assessed by Northern blot analysis at the time of relapse compared with pretreatment in two patients who were tested. These results indicate that clinical relapse and “resistance” to continuous treatment with all- trans RA in APL is associated with progressive reduction of plasma concentrations, potentially to levels below those that sustain differentiation of leukemic cells in vivo. Long-term success of this treatment will require the development of strategies that circumvent this pharmacologic phenomenon.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood.v79.2.299.299

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 2

Brazzell RK, Colburn WA: Pharmacokinetics of the retin- oids isotretinoin and etretinate: A comparative review. J Am Acad Dermatol6:643, 1982
Francis PA, Riggs JR, Muindi JR, Kris MG, Young CW, Warrell RP Jr: Modulation of all-trans retinoic acid (RA) pharma- cokinetics by a cytochrome P-450 enzyme system inhibitor. Proc Am Soc Clin Oncol (in press)

Sorted by citations

Acute Promyelocytic Leukemia
Warrell, R. P., de Thé, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 778
Self-citation
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
Fenaux, P., Chastang, C., Chevret, S., Sanz, M. Á., Dombret, H., Archimbaud, E., Fey, M. F., Rayón, C., Huguet, F., Sotto, J., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192 · Cited by 747
The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 579
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
de Thé, H., & Zhu, C. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2943 · Cited by 490
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Pérès, L., Berthier, C., Rousselot, P. H., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1891 · Cited by 354
Teratology of Retinoids
Collins, M. D., & Mao, G. E. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.399 · Cited by 290
All trans retinoic acid in acute promyelocytic leukemia
Degos, L., & Wang, Z. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204763 · Cited by 273
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Wei, S., Kozono, S., Kats, L., Nechama, M., Li, W., Guarnerio, J., Luo, M., You, M.-H., Yao, Y., Kondo, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3839 · Cited by 272
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 275
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Bruno, R. D., & Njar, V. C. O. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.046 · Cited by 255
Treatment With a New Synthetic Retinoid, Am80, of Acute Promyelocytic Leukemia Relapsed From Complete Remission Induced by All-trans Retinoic Acid
Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., MIYAWAKI, S., Ueda, R., et al. (1997) · Blood · doi:10.1182/blood.v90.3.967 · Cited by 198
Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
Ablain, J., Rice, K. L., Soilihi, H., de Reyniès, A., Minucci, S., & de Thé, H. (2014) · Nature Medicine · doi:10.1038/nm.3441 · Cited by 200
Diverse actions of retinoid receptors in cancer prevention and treatment
Mongan, N. P., & Gudas, L. J. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00206.x · Cited by 182
A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema
Mao, J. T., Goldin, J. G., Dermand, J. C., Ibrahim, G., Brown, M. S., Emerick, A. M., McNitt‐Gray, M. F., Gjertson, D. W., ESTRADA, F., Tashkin, D. P., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.5.2106123 · Cited by 175
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
Fenaux, P., Chevret, S., Guerci‐Bresler, A., Fegueux, N., Dombret, H., Thomas, X., Sanz, M. Á., Link, H., Maloisel, F., Gardin, C., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401859 · Cited by 169
Feasibility of Retinoids for the Treatment of Emphysema Study
Roth, M. D., Connett, J. E., D'Armiento, J. M., Foronjy, R., Friedman, P. J., Goldin, J. G., Louis, T. A., Mao, J. T., Muindi, J. R., O’Connor, G. T., et al. (2006) · CHEST Journal · doi:10.1378/chest.130.5.1334 · Cited by 161
Self-citation
Retinoid Metabolism in the Skin
Roos, T. C., Jugert, F. K., Merk, H. F., & Bickers, D. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01364-4 · Cited by 162
Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer
Niles, R. M. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00436-6 · Cited by 150
Cancer of the corpus uteri in white and black women in Michigan, 1985-1994
Madison, T., Schottenfeld, D., & Baker, V. M. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8 · Cited by 27
Self-citation
Mechanistic aspects of carotenoid health benefits – where are we now?
Bohn, T., Bonet, M. L., Borel, P., Keijer, J., Landrier, J., Milisav, I., Ribot, J., Riso, P., Winklhofer‐Roob, B. M., Sharoni, Y., et al. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000147 · Cited by 155
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases
Njar, V. C. O., Gediya, L. K., Purushottamachar, P., Chopra, P., Vasaitis, T. S., Khandelwal, A., Mehta, J., Huynh, C., Belosay, A., & Patel, J. B. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.02.041 · Cited by 147
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
de Botton, S., Chevret, S., Sanz, M. Á., Dombret, H., Thomas, X., Guerci‐Bresler, A., Fey, M. F., Rayón, C., Huguet, F., Sotto, J., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02442.x · Cited by 158
Retinoic acid resistance in acute promyelocytic leukemia
Gallagher, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402719 · Cited by 142
Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation
Lc, M., & Daly, A. K. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00356-7 · Cited by 141
Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine
Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist
McKeown, M. R., Corces, M. R., Eaton, M. L., Fiore, C., Lee, E., Lopez, J. T., Chen, M. W., Smith, D., Chan, S. M., Koenig, J. L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0399 · Cited by 134
Leukemic Cellular Retinoic Acid Resistance and Missense Mutations in the PML-RAR Fusion Gene After Relapse of Acute Promyelocytic Leukemia From Treatment With All-trans Retinoic Acid and Intensive Chemotherapy
Ding, W., Li, Y., Nobile, L. M., Grills, G., Carrera, I., Paietta, E. M., Tallman, M. S., Wiernik, P. H., & Gallagher, R. E. (1998) · Blood · doi:10.1182/blood.v92.4.1172 · Cited by 125
Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders
Lim, S., Lee, M., & Kim, C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.032 · Cited by 128
RETINOID THERAPY OF CHILDHOOD CANCER
Reynolds, C. P., & Lemons, R. S. (2001) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70256-2 · Cited by 127
Revisiting the differentiation paradigm in acute promyelocytic leukemia
Ablain, J., & de Thé, H. (2011) · Blood · doi:10.1182/blood-2011-02-329367 · Cited by 124
All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells
Li, R.-J., Ying, X., Zhang, Y., Ju, R.-J., Wang, X.-X., Yao, H.-J., Men, Y., Tian, W., Yu, Y., Zhang, L., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.019 · Cited by 119
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia
Sanz, M. Á., Tallman, M. S., & Lo‐Coco, F. (2004) · Blood · doi:10.1182/blood-2004-09-3475 · Cited by 117
Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes
Nadin, L., & Murray, M. T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00192-6 · Cited by 113
The Retinoids and Cancer Prevention Mechanisms
Dragnev, K. H., Rigas, J. R., & Dmitrovsky, E. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-361 · Cited by 110
Self-citation
Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer
Pae, H., Seo, W.-G., Kim, N.-Y., Oh, G., Kim, G. E., Kim, Y.-H., Kwak, H. J., Yun, Y., Jun, C., & Chung, H. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00138-7 · Cited by 109
Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia
Estey, E. H., Giles, F. J., Kantarjian, H., O’Brien, S., Cortes, J., Freireich, E. J., Lopez-Berestein, G., & Keating, M. (1999) · Blood · doi:10.1182/blood.v94.7.2230.419k05_2230_2235 · Cited by 105
Mutations in the E-Domain of RARα Portion of the PML/RARα Chimeric Gene May Confer Clinical Resistance to All-transRetinoic Acid in Acute Promyelocytic Leukemia
Imaizumi, M., Suzuki, H., Yoshinari, M., Sato, A., Saito, T., Sugawara, A., Tsuchiya, S., Hatae, Y., Fujimoto, T., Kakizuka, A., et al. (1998) · Blood · doi:10.1182/blood.v92.2.374 · Cited by 102
How to manage acute promyelocytic leukemia
Mi, J.-Q., Li, J., Shen, Z.-X., Chen, S.-J., & Chen, Z. (2012) · Leukemia · doi:10.1038/leu.2012.57 · Cited by 97
Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer
Stevison, F., Jing, J., Tripathy, S., & Isoherranen, N. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.006 · Cited by 98
HumanMDR1and Mousemdr1aP-Glycoprotein Alter the Cellular Retention and Disposition of Erythromycin, but Not of Retinoic Acid or Benzo(a)pyrene
Schuetz, E. G., Yasuda, K., Arimori, K., et al. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0537 · Cited by 94
Treatment of acute promyelocytic leukaemia
Fenaux, P., Chomienne, C., & Degos, L. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0121 · Cited by 91
Current Trends in ATRA Delivery for Cancer Therapy
Giuli, M. V., Hanieh, P. N., Giuliani, E., Rinaldi, F., Marianecci, C., Screpanti, I., Checquolo, S., & Carafa, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080707 · Cited by 97
Polyion Complex Micelles Composed of All-TranS Retinoic Acid and Poly (Ethylene Glycol)-Grafted-Chitosan
Jeong, Y.-I., Kim, S.-H., Jung, T.-Y., Kim, I.-Y., Kang, S.-S., Jin, Y.-H., Ryu, H.-H., Sun, H.-S., Jin, S., Kim, K.-K., et al. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20586 · Cited by 90
Treatment concepts of acute promyelocytic leukemia
Lengfelder, E., Saußele, S., Weisser, A., et al. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.08.009 · Cited by 88
Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia
Wang, H., Zheng, X., Behm, F. G., & Ratnam, M. (2000) · Blood · doi:10.1182/blood.v96.10.3529 · Cited by 88
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
heusden, J. V., Ginckel, R. V., Bruwiere, H., Moelans, P., Janssen, B., Floren, W., van der Leede, B. J., Dun, J. V., Sanz, G., Venet, M., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600056 · Cited by 86
Treatment of Acute Promyelocytic Leukemia
Sanz, M. Á. (2006) · Hematology · doi:10.1182/asheducation-2006.1.147 · Cited by 85
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo
Fazi, F., Travaglini, L., Carotti, D., Palitti, F., Diverio, D., Alcalay, M., McNamara, S., Miller, W. H., Lo‐Coco, F., Pelicci, P. G., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208286 · Cited by 81
Self-citation
All-trans retinoic acid in acute promyelocytic leukaemia
Avvisati, G., & Tallman, M. S. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00057-4 · Cited by 81
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-transretinoic acid
Douer, D., Estey, E. H., Santillana, S., Bennett, J. M., Lopez-Bernstein, G., Boehm, K. A., & Williams, T. (2001) · Blood · doi:10.1182/blood.v97.1.73 · Cited by 79
All-trans-retinoic acid: a phase II radiation therapy oncology group study (RTOG 91-13) in patients with recurrent malignant astrocytoma
Phuphanich, S., Scott, C., Fischbach, A. J., Langer, C. J., & Yung, W. K. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005765915288 · Cited by 76
Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration
Hwang, S. R., Lim, S., Park, J., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.025 · Cited by 76
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia
Schwartz, E. L., Hallam, S., Gallagher, R. E., & Wiernik, P. H. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00213-j · Cited by 75
Retinoic Acids in the Treatment of Most Lethal Solid Cancers
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020360 · Cited by 74
Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids
Topletz, A. R., Tripathy, S., Foti, R., Shimshoni, J. A., Nelson, W. L., & Isoherranen, N. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.096784 · Cited by 79
A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways
Yang, D., Luo, W., Wang, J., Zheng, M., Liao, X., Zhang, N., Lu, W., Wang, L., Chen, A., Wu, W., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.031 · Cited by 69
Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles
Akanda, M., Rai, R., Slipper, I. J., Chowdhry, B. Z., Lamprou, D. A., Getti, G. T. M., & Douroumis, D. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.042 · Cited by 73
All-trans-retinoic acid release from core-shell type nanoparticles of poly(ε-caprolactone)/poly(ethylene glycol) diblock copolymer
Jeong, Y., Kang, M.-K., Sun, H.-S., Kang, S.-S., Kim, H., Moon, K., Lee, K.-J., Kim, S.-H., & Jung, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.012 · Cited by 69
Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid
Mehta, K., Sadeghi, T., McQueen, T., & Lopez-Berestein, G. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90040-x · Cited by 67
Treatment of Acute Promyelocytic Leukemia by Retinoids
Fenaux, P., Wang, Z., & Degos, L. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-34594-7_7 · Cited by 65
Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia
Côté, S., Zhou, D.-C., Bianchini, A., Nervi, C., Gallagher, R. E., & Miller, W. H. (2000) · Blood · doi:10.1182/blood.v96.9.3200 · Cited by 66
Self-citation
PATHOGENESIS AND MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
Warrell, R. P. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.555 · Cited by 60
Self-citation
Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids
Chlapek, P., Sláviková, V., Mazánek, P., Štěrba, J., & Veselská, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010132 · Cited by 66
Modulation of all-trans retinoic acid pharmacokinetics by liarozole
Miller, V. A., Rigas, J. R., Muindi, J. R., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685665 · Cited by 63
Self-citation
Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cells
Côté, S., Rosenauer, A., Bianchini, A., Seiter, K. P., Vandewiele, J., Nervi, C., & Miller, W. H. (2002) · Blood · doi:10.1182/blood-2002-02-0614 · Cited by 62
Self-citation
Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia
Chen, Z., Tong, J., Dong, S., Zhu, J., Wang, Z., & Chen, S. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199603)15:3 · Cited by 57
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group
on behalf of the UKCCSG Pharmacology Working Group, Veal, G. J., Cole, M. F., Errington, J., Pearson, A. D. J., Foot, A. B. M., Whyman, G., & Boddy, A. V. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603554 · Cited by 57
Acute effects of dietary retinoic acid on ocular components in the growing chick
McFadden, S. A., Howlett, M. H. C., Mertz, J. R., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.05.002 · Cited by 55
Lung Cancer Prevention*
Dragnev, K. H., Stover, D. E., & Dmitrovsky, E. (2003) · CHEST Journal · doi:10.1378/chest.123.1_suppl.60s · Cited by 55
Self-citation
Adaptive Dosing Approaches to the Individualization of 13- Cis -Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma
Veal, G. J., Errington, J., Rowbotham, S. E., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2225 · Cited by 54
Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres
Choi, Y., Kim, S. Y., Kim, S. H., Lee, K.-S., Kim, C., & Byun, Y. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00676-1 · Cited by 54
Retinoic Acid Receptors Regulate Expression of Retinoic Acid 4-Hydroxylase that Specifically Inactivates All-Trans Retinoic Acid in Human Keratinocyte HaCaT Cells
Marikar, Y., Wang, Z., Petkovich, M. P., Voorhees, J. J., Fisher, G. J., & Duell, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00297.x · Cited by 54
HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells
Ikezoe, T., Daar, E. S., Hisatake, J., Taguchi, H., & Koeffler, H. P. (2000) · Blood · doi:10.1182/blood.v96.10.3553 · Cited by 57
Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma
Boorjian, S. A., Milowsky, M. I., Kaplan, J., Albert, M., Cobham, M. V., Coll, D. M., Mongan, N. P., Shelton, G., Petrylak, D. P., Gudas, L. J., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31805449a8 · Cited by 52
Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
Armstrong, J. L., Ruiz, M. T., Boddy, A. V., Redfern, C. P. F., Pearson, A. D. J., & Veal, G. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602398 · Cited by 50
Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients: Toxicity, Pharmacokinetic, and Biomarker Evaluations
Lawrence, J. A., Adamson, P. C., Caruso, R. C., Chow, C., Kleiner, D. E., Murphy, R. F., Venzon, D. J., Shovlin, M., Noone, M., Merino, M. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2754 · Cited by 49
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
Shen, Y., Fu, Y., Zhu, Y., Lou, Y., Gu, Z., Shi, J., Chen, B., Chen, C., Zhu, H., Hu, J., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.04.006 · Cited by 48
Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways
Liao, X.-H., Zhang, A. L., Zheng, M., Li, M.-Q., Chen, C. P., Xu, H., Chu, Q., Yang, D., Lu, W., Tsai, T., et al. (2017) · Scientific Reports · doi:10.1038/srep43639 · Cited by 48
Targeting of PML/RAR Is Lethal to Retinoic Acid–Resistant Promyelocytic Leukemia Cells
Nason-Burchenal, K., Allopenna, J. J., Begue, A., Stéhelin, D., Dmitrovsky, E., & Martin, P. (1998) · Blood · doi:10.1182/blood.v92.5.1758 · Cited by 48
Self-citation
Retinoid receptor signaling and autophagy in acute promyelocytic leukemia
Orfali, N., McKenna, S. L., Cahill, M. R., Gudas, L. J., & Mongan, N. P. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.018 · Cited by 47
All-Trans-Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia
Adamson, P. C. (1996) · The Oncologist · doi:10.1634/theoncologist.1-5-305 · Cited by 46
N-Phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles
Opanasopit, P., Ngawhirunpat, T., Rojanarata, T., Choochottiros, C., & Chirachanchai, S. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.01.002 · Cited by 45
Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
Jing, J., Nelson, C., Paik, J., Shirasaka, Y., Amory, J. K., & Isoherranen, N. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240523 · Cited by 45
Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration
Kawakami, S., Opanasopit, P., Yokoyama, M., Chansri, N., Yamamoto, T., Okano, T., Yamashita, F., & Hashida, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20487 · Cited by 44
The molecular biology of acute promyelocytic leukemia
Slack, J. L., & Gallagher, R. E. (2007) · Springer eBooks · doi:10.1007/978-0-585-38571-6_4 · Cited by 44
Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells
Gomaa, M. S., Armstrong, J. L., Bobillon, B., Veal, G. J., Brancale, A., Redfern, C. P. F., & Simons, C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.048 · Cited by 42
Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance
Wang, T., Ma, X., Krausz, K. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131045 · Cited by 43
All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells
Nakajima, H., Kizaki, M., Ueno, H., Muto, A., Takayama, N., Matsushita, H., Sonoda, A., & Ikeda, Y. (1996) · Leukemia Research · doi:10.1016/0145-2126(96)00020-3 · Cited by 41
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells
Özpolat, B., Mehta, K., & Lopez‐Berestein, G. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500174737 · Cited by 41
Chemotherapeutic strategies for renal cell carcinoma
Milowsky, M. I., & Nanus, D. M. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(03)00031-4 · Cited by 39
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization
Nason-Burchenal, K., Maerz, W., Allopenna, J. J., Martin, P., Dmitrovsky, E., Albanell, J., & Moore, M. A. S. (1997) · Differentiation · doi:10.1046/j.1432-0436.1997.6150321.x · Cited by 39
Self-citation
Substrate Specificity and Ligand Interactions of CYP26A1, the Human Liver Retinoic Acid Hydroxylase
Thatcher, J. E., Buttrick, B., Shaffer, S. A., Shimshoni, J. A., Goodlett, D. R., Nelson, W. L., & Isoherranen, N. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072413 · Cited by 39
Retinoic acid in the treatment of acute promyelocytic leukemia: Inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events
Runde, V., Aul, C., Südhoff, T., et al. (1992) · Annals of Hematology · doi:10.1007/bf01695469 · Cited by 39
Distinguishing between cancer cell differentiation and resistance induced by all-trans retinoic acid using transcriptional profiles and functional pathway analysis
Liu, S.-M., Chen, W., & Wang, J. (2014) · Scientific Reports · doi:10.1038/srep05577 · Cited by 38
Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma
Hong, G.-Y., Jeong, Y., Lee, S. J., Lee, E., Oh, J. S., & Lee, H. C. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0308-8 · Cited by 37
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
de Botton, S., Cluzeau, T., Vigil, C. E., Cook, R. J., Rousselot, P. H., Rizzieri, D. A., Liesveld, J. L., Fenaux, P., Braun, T., Banos, A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008806 · Cited by 38
Varying responses of PML-RARA with different genetic mutations to arsenic trioxide
Liu, J., Zhu, H., Jiang, H., Jiang, Q., & Huang, X. (2015) · Blood · doi:10.1182/blood-2015-04-637678 · Cited by 36
Relapsed Acute Promyelocytic Leukemia Previously Treated with All-Trans Retinoic Acid: Clinical Experience with a New Synthetic Retinoid, Am-80
Takeuchi, M., Yano, T., Omoto, E., Takahashi, K., Kibata, M., Shudo, K., Harada, M., Uedad, R., & Ohno, R. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057604 · Cited by 35
PHASE II STUDY OF ALL-TRANS RETINOIC ACID ADMINISTERED INTERMITTENTLY FOR HORMONE REFRACTORY PROSTATE CANCER
Culine, S., Kramar, A., Droz, J., & Théodore, C. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62090-1 · Cited by 36
Antitumor Effect of All-Trans Retinoic Acid-Encapsulated Nanoparticles of Methoxy Poly(Ethylene Glycol)-Conjugated Chitosan Against CT-26 Colon Carcinoma In Vitro
Park, J., Koh, Y., Bang, J.-Y., Jeong, Y., & Lee, J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21221 · Cited by 35

Authors: Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J.
Affiliations: Memorial Sloan Kettering Cancer Center (US)
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
ORCID: Jakubowski, A
Dmitrovsky, E
Venue: Blood
Publisher: American Society of Hematology
Published: 1992-01-15
Volume: 79
Issue: 2
Pages: 299-303
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood.v79.2.299.299
OpenAlex: W4246713397
Cited by: 314
References: 0
Citations by year: 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 12 · 2014: 9 · 2012: 7
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: all-trans retinoic acid, acute promyelocytic leukemia, relapse, drug resistance, plasma drug concentration, pharmacokinetics, leukemia cell differentiation, dose escalation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks